1. A regulatory role for CHD2 in myelopoiesis
- Author
-
Mickaël Durand-Dubief, J. Peter Svensson, Andreas Lennartsson, Wenbo Dong, Jenna Persson, Anna Palau, and Farzaneh Shahin Varnoosfaderani
- Subjects
0301 basic medicine ,Cancer Research ,Myeloid ,Biology ,Cell fate determination ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Epigenetics ,Molecular Biology ,Cell Proliferation ,Myelopoiesis ,epigenetics ,Chromatin Assembly and Disassembly ,CHD2 ,Chromatin ,Cell biology ,DNA-Binding Proteins ,Haematopoiesis ,030104 developmental biology ,medicine.anatomical_structure ,Histone ,030220 oncology & carcinogenesis ,DNA methylation ,CRISPR-Cas9 library ,biology.protein ,Tetradecanoylphorbol Acetate ,K562 Cells ,Megakaryocytes ,Research Article ,Research Paper - Abstract
The transcriptional program that dictates haematopoietic cell fate and differentiation requires an epigenetic regulatory and memory function, provided by a network of epigenetic factors that regulate DNA methylation, post-translational histone modifications and chromatin structure. Disturbed epigenetic regulation causes perturbations in the blood cell differentiation program that results in various types of haematopoietic disorders. Thus, accurate epigenetic regulation is essential for functional haematopoiesis. In this study, we used a CRISPR-Cas9 screening approach to identify new epigenetic regulators in myeloid differentiation. We designed a Chromatin-UMI CRISPR guide library targeting 1092 epigenetic regulators. Phorbol 12-myristate 13-acetate (PMA) treatment of the chronic myeloid leukaemia cell line K-562 was used as a megakaryocytic myeloid differentiation model. Both previously described developmental epigenetic regulators and novel factors were identified in our screen. In this study, we validated and characterized a role for the chromatin remodeller CHD2 in myeloid proliferation and megakaryocytic differentiation.
- Published
- 2020
- Full Text
- View/download PDF